| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.dipnapharmachem.com | |
| Market Cap | 20.80 Cr. | |
| Enterprise Value(EV) | 39.81 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.38 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 22.81 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 63.93 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 15.15 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 0.57 | Calculated using Price: 8.65 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 2.40 Cr. | 24,045,250 Shares |
| FaceValue | 10 | |
| About Dipna Pharmachem Ltd. | ||
| Dipna Pharmachem is a trader, importer, and exporter in industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation since 2011. The company’s huge portfolio includes expertise for marketing and sourcing of industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation and intermediates, assistance in setting up contract manufacturing compliance for regulated, semi-regulated pharmaceutical companies with all the global benchmark parameters of leading certificates like WHO-GMP. | ||
| 1 Day |
|
-5.06% |
| 1 Week |
|
-8.48% |
| 1 Month |
|
-14.30% |
| 3 Month |
|
-28.62% |
| 6 Month |
|
-25.80% |
| 1 Year |
|
-34.77% |
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 13.24 | 6.78 | 11.39 | 4.32 | 101.02 | 6.99 | |
| Return on Capital Employed (%) | 7.16 | 7.98 | 5.42 | 3.54 | 18.16 | 9.58 | |
| Return on Assets (%) | 0.55 | 0.25 | 0.36 | 0.11 | 3.82 | 1.6 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 0 | 0 | 1 | 1 | 2 | 24 | 25 | |
| Non Curr. Liab. | 3 | 4 | 6 | 14 | 16 | |||
| Curr. Liab. | 11 | 14 | 15 | 21 | 29 | 39 | 64 | |
| Minority Int. | ||||||||
| Equity & Liab. | 11 | 14 | 18 | 25 | 36 | 78 | 104 | |
| Non Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Curr. Assets | 11 | 14 | 18 | 25 | 36 | 78 | 104 | |
| Misc. Exp. not W/O | ||||||||
| Total Assets | 11 | 14 | 18 | 25 | 36 | 78 | 104 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 17 | 20 | 31 | 31 | 73 | 100 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 17 | 20 | 31 | 31 | 73 | 100 | |
| Total Expenditure | -16 | -20 | -30 | -31 | -71 | -97 | |
| PBIDT | 0 | 0 | 0 | 0 | 2 | 3 | |
| Interest | 0 | 0 | 0 | 0 | -1 | -1 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | ||
| Taxation | 0 | 0 | 0 | 0 | 0 | ||
| Exceptional Items | |||||||
| PAT | 0 | 0 | 0 | 0 | 1 | 1 | |
| Adjusted EPS | 3 | 2 | 3 | 1 | 57 | 1 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -3 | -2 | 3 | -21 | |||
| Cash Fr. Inv. | 0 | 0 | 0 | ||||
| Cash Fr. Finan. | 3 | 3 | -3 | 26 | |||
| Net Change | 0 | 0 | 0 | 5 | |||
| Cash & Cash Eqvt | 0 | 0 | 0 | 6 |
|
Mon, 06 May 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th May 2024 Outcome of Board Meeting held on 6th May 2024 |
|
Thu, 02 May 2024
Board Meeting Intimation for Re-Schedule Of Board Meeting Held Today I.E. 2Nd May 2024 Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 inter alia to consider and approve Pursuant to the second proviso to Regulation 30(6) of the SEBI (LODR) Regulations 2015 we hereby inform you the Board of Directors of the Company meeting held today i.e. Thursday 2nd May 2024 which commenced at 2:00 P.M. and Concluded at 7:30 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India 380055 has decided to Re-schedule the meeting to be held on 6th May 2024 for discuss and consider inter-alia:? The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company.? The proposal of sub-division of equity shares of the Company.? The proposal of raising of funds by way of issue of Equity shares and/ or Warrants onpreferential basis.Note that meeting is reschedule due to requirement of expert advice. |
|
Wed, 01 May 2024
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Statement on Deviation or Variation of funds under Regulation 32 of SEBI (LODR) Regulations 2015. |
| Mon, 06 May 2024 |
Opening at High
|
Close Within 52 Week Low Zone
|
High Decrease in 1 Month
|
High Decrease in 3 Months
|
High Decrease in 6 Months
|
